Explore

Trendline Trendline
TherapeuticsMD Reports Improved Financial Results and Strategic Exploration

TherapeuticsMD Reports Improved Financial Results and Strategic Exploration

TherapeuticsMD Reports Improved Financial Results and Strategic Exploration
Trendline Trendline
Natura Faces Revenue Pressure Amid Economic Challenges in Brazil and Argentina

Natura Faces Revenue Pressure Amid Economic Challenges in Brazil and Argentina

Natura Faces Revenue Pressure Amid Economic Challenges in Brazil and Argentina
Trendline Trendline
Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements

Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements

Imunon, Inc. Reports Increased Net Loss in Q1 2026 Amid Clinical Advancements
Trendline Trendline
Compass Diversified Reports Q1 2026 Earnings with Strategic Divestiture

Compass Diversified Reports Q1 2026 Earnings with Strategic Divestiture

Compass Diversified Reports Q1 2026 Earnings with Strategic Divestiture
Trendline Trendline
Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline

Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline

Anteris Technologies Reports Q1 2026 Financial Results with Revenue Decline
Trendline Trendline
Natura Reports Q1 2026 Financials Amid Economic Challenges in Brazil

Natura Reports Q1 2026 Financials Amid Economic Challenges in Brazil

Natura Reports Q1 2026 Financials Amid Economic Challenges in Brazil
Trendline Trendline
Harmonic Reports Strong Q1 2026 Results with Significant Broadband Revenue Growth

Harmonic Reports Strong Q1 2026 Results with Significant Broadband Revenue Growth

Harmonic Reports Strong Q1 2026 Results with Significant Broadband Revenue Growth
Trendline Trendline
Harmonic Reports Strong Q1 2026 Results with Increased Broadband Revenue

Harmonic Reports Strong Q1 2026 Results with Increased Broadband Revenue

Harmonic Reports Strong Q1 2026 Results with Increased Broadband Revenue
Trendline Trendline
Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates

Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates

Turn Therapeutics Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials

Curis Reports First Quarter 2026 Financial Results Amid Ongoing Clinical Trials
Trendline Trendline
Zimmer Biomet Increases Share Repurchase Expectations to $1 Billion by Year End

Zimmer Biomet Increases Share Repurchase Expectations to $1 Billion by Year End

Zimmer Biomet Increases Share Repurchase Expectations to $1 Billion by Year End
Trendline Trendline
Conduent Reports Improved Financial Performance in Q1 2026 Amid Strategic Transformations

Conduent Reports Improved Financial Performance in Q1 2026 Amid Strategic Transformations

Conduent Reports Improved Financial Performance in Q1 2026 Amid Strategic Transformations